The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.

Beyer-Westendorf J, Fay M, Amara W

Open source

DOI
10.1055/s-0041-1731777
Published
2021 Jul
Container
TH open : companion journal to thrombosis and haemostasis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/s-0041-1731777,
  title = {The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.},
  author = {Beyer-Westendorf J and Fay M and Amara W},
  year = {2021},
  journal = {TH open : companion journal to thrombosis and haemostasis},
  doi = {10.1055/s-0041-1731777},
  url = {https://doi.org/10.1055/s-0041-1731777}
}

RIS

TY  - JOUR
TI  - The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.
AU  - Beyer-Westendorf J
AU  - Fay M
AU  - Amara W
PY  - 2021
JO  - TH open : companion journal to thrombosis and haemostasis
DO  - 10.1055/s-0041-1731777
UR  - https://doi.org/10.1055/s-0041-1731777
ER  - 

APA

J, B., M, F., & W, A. (2021). The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.. TH open : companion journal to thrombosis and haemostasis. https://doi.org/10.1055/s-0041-1731777

Source records